DC-50-QD52_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, Cts-1027, MMP-14 (Membrane-Type Matrix Metalloproteinase 1) Inhibitors;MMP-12 (Macrophage Elastase) Inhibitors;MMP-13 (Collagenase 3) Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-3 (Stromelysin 1) Inhibitors;MMP-8 (Neutrophil Collagenase) Inhibitors;MMP-2 (Gelatinase A) Inhibitors targeting MMP14, MMP11, MMP15, MMP16, MMP17, MMP19, MMP23A, MMP20, MMP27, MMP28, MMP21 (Novartis, 3342298)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/3342298
Similar Terms
Downloads & Tools

Genes

9 genes differentially expressed following the DC-50-QD52_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
CCT7 chaperonin containing TCP1, subunit 7 (eta) 0.625564
DDIT4 DNA-damage-inducible transcript 4 0.406584
SF3B6 splicing factor 3b, subunit 6, 14kDa 0.339569
ABHD14B abhydrolase domain containing 14B 0.255142
NDUFS4 NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) 0.2448
RNF138 ring finger protein 138, E3 ubiquitin protein ligase 0.214678

decreased expression

Symbol Name Standardized Value
PITHD1 PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1 -0.276942
CPSF6 cleavage and polyadenylation specific factor 6, 68kDa -0.255142
RBM39 RNA binding motif protein 39 -0.202032